Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $23,747 - $28,077
1,244 Added 37.02%
4,604 $90,000
Q1 2024

May 15, 2024

SELL
$21.55 - $29.29 $112,878 - $153,421
-5,238 Reduced 60.92%
3,360 $72,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $203,256 - $260,261
8,598 New
8,598 $248,000
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $13,992 - $23,520
369 Added 51.04%
1,092 $42,000
Q2 2022

Aug 08, 2022

SELL
$47.98 - $62.75 $93,608 - $122,425
-1,951 Reduced 72.96%
723 $39,000
Q3 2021

Nov 15, 2021

SELL
$74.87 - $110.87 $73,672 - $109,096
-984 Reduced 26.9%
2,674 $241,000
Q1 2021

May 17, 2021

SELL
$59.3 - $183.85 $107,510 - $333,320
-1,813 Reduced 33.14%
3,658 $353,000
Q4 2020

Feb 16, 2021

BUY
$31.01 - $52.1 $169,655 - $285,039
5,471 New
5,471 $285,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.